JP2022516086A5 - - Google Patents
Info
- Publication number
- JP2022516086A5 JP2022516086A5 JP2021537220A JP2021537220A JP2022516086A5 JP 2022516086 A5 JP2022516086 A5 JP 2022516086A5 JP 2021537220 A JP2021537220 A JP 2021537220A JP 2021537220 A JP2021537220 A JP 2021537220A JP 2022516086 A5 JP2022516086 A5 JP 2022516086A5
- Authority
- JP
- Japan
- Prior art keywords
- fluorine
- atom
- compound according
- atoms
- chlorine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/235,543 | 2018-12-28 | ||
| US16/235,543 US10752593B2 (en) | 2018-12-28 | 2018-12-28 | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
| PCT/US2019/068759 WO2020140043A1 (en) | 2018-12-28 | 2019-12-27 | Compounds for use as therapeutically active substances in the treatment and/or prevention of neuroretinal diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022516086A JP2022516086A (ja) | 2022-02-24 |
| JP2022516086A5 true JP2022516086A5 (https=) | 2022-11-30 |
Family
ID=69188012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021537220A Withdrawn JP2022516086A (ja) | 2018-12-28 | 2019-12-27 | 神経網膜疾患の治療および／または予防における治療活性物質として使用するための化合物 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US10752593B2 (https=) |
| EP (1) | EP3902606A1 (https=) |
| JP (1) | JP2022516086A (https=) |
| KR (1) | KR20210110849A (https=) |
| CN (1) | CN113301958A (https=) |
| AU (1) | AU2019414950A1 (https=) |
| BR (1) | BR112021011599A2 (https=) |
| CA (1) | CA3125278A1 (https=) |
| CL (1) | CL2021001725A1 (https=) |
| EA (1) | EA202191057A1 (https=) |
| IL (1) | IL284298A (https=) |
| MX (1) | MX2021007813A (https=) |
| PH (1) | PH12021551092A1 (https=) |
| SG (1) | SG11202104958UA (https=) |
| WO (1) | WO2020140043A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10807973B2 (en) | 2018-12-28 | 2020-10-20 | Endogena Therapeutics, Inc. | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998010758A1 (en) | 1996-09-13 | 1998-03-19 | The Regents Of The University Of California | Methods for treatment of retinal diseases |
| CA2216439A1 (en) | 1996-09-25 | 1998-03-25 | Derek Van Der Kooy | Pharmaceuticals containing retinal stem cells |
| WO2001039792A2 (en) | 1999-12-03 | 2001-06-07 | Alcon Universal Ltd. | The use of caspase 9 inhibitors to treat ocular neural pathology |
| AU2008335709A1 (en) | 2007-12-13 | 2009-06-18 | Amgen Inc. | Gamma secretase modulators |
| US9018202B2 (en) | 2010-12-03 | 2015-04-28 | Allergan, Inc. | Methods for treating diseases of the retina |
| US20130046003A1 (en) | 2011-07-22 | 2013-02-21 | Mohammed I. Dibas | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| WO2013029338A1 (en) | 2011-09-01 | 2013-03-07 | Glaxo Group Limited | Novel compounds |
| WO2014079850A1 (en) | 2012-11-23 | 2014-05-30 | F. Hoffmann-La Roche Ag | Substituted heterocyclic derivatives |
| DE102013110714A1 (de) | 2013-09-27 | 2015-04-02 | Eberhard Karls Universität Tübingen Medizinische Fakultät | Prophylaxe und Behandlung einer nicht auf einer Proteinfaltungsstörung beruhenden neurodegenerativen Erkrankung |
| BR112017009584A2 (pt) | 2014-11-07 | 2017-12-26 | Nacuity Pharmaceuticals Inc | tratamento de retinite pigmentosa com n-acetilcisteína amida |
-
2018
- 2018-12-28 US US16/235,543 patent/US10752593B2/en not_active Expired - Fee Related
-
2019
- 2019-12-27 MX MX2021007813A patent/MX2021007813A/es unknown
- 2019-12-27 EA EA202191057A patent/EA202191057A1/ru unknown
- 2019-12-27 WO PCT/US2019/068759 patent/WO2020140043A1/en not_active Ceased
- 2019-12-27 CA CA3125278A patent/CA3125278A1/en active Pending
- 2019-12-27 AU AU2019414950A patent/AU2019414950A1/en not_active Abandoned
- 2019-12-27 EP EP19842557.1A patent/EP3902606A1/en not_active Withdrawn
- 2019-12-27 KR KR1020217023914A patent/KR20210110849A/ko not_active Ceased
- 2019-12-27 BR BR112021011599-4A patent/BR112021011599A2/pt not_active Application Discontinuation
- 2019-12-27 CN CN201980085675.1A patent/CN113301958A/zh active Pending
- 2019-12-27 JP JP2021537220A patent/JP2022516086A/ja not_active Withdrawn
- 2019-12-27 SG SG11202104958UA patent/SG11202104958UA/en unknown
-
2021
- 2021-05-11 PH PH12021551092A patent/PH12021551092A1/en unknown
- 2021-06-22 IL IL284298A patent/IL284298A/en unknown
- 2021-06-25 CL CL2021001725A patent/CL2021001725A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020122957A5 (https=) | ||
| CN112566907A (zh) | 作为ret抑制剂的吡唑衍生物 | |
| JP2020534390A5 (https=) | ||
| JP2017128738A5 (https=) | ||
| JP1729863S (ja) | 組立て遊戯具用ブロック | |
| JP2016026249A5 (https=) | ||
| JP2020504434A5 (https=) | ||
| JP2023508938A5 (https=) | ||
| JP2022516086A5 (https=) | ||
| MX2021007505A (es) | Síntesis de 3-metil-1,2,4-tiadiazol-5-carbohidrazida o de su forma deuterada con metil-d3. | |
| JP2019016740A5 (https=) | ||
| CN111868060A (zh) | 二氢吡啶并酞嗪酮衍生物、其制备方法及应用 | |
| JP2020161765A5 (https=) | ||
| CN111836819A (zh) | 一种含有芳胺基取代的吡咯并嘧啶类化合物、制备方法及其应用 | |
| Miska | Arithmetic properties of the sequence of derangements | |
| JP2021501685A5 (https=) | ||
| JP2021530432A5 (https=) | ||
| JP2018518562A5 (https=) | ||
| JP2010282728A5 (https=) | ||
| CN113286798A (zh) | 内环硫脒酰胺-芳基酰胺类化合物及其治疗乙型肝炎的用途 | |
| JP2022077370A5 (https=) | ||
| Vianu | Invited Articles Foreword | |
| USD52684S (en) | Willard stba-ctb | |
| JPWO2024111491A5 (https=) | ||
| JP1733526S (ja) | 照明器具 |